دكساميسين

main_info

  • trade_name:
  • دكساميسين
  • pharmaceutical_form:
  • OPHTHALMIC SOLUTION
  • administration_route:
  • OCULAR
  • medicine_domain:
  • Human
  • medicine_type:
  • Allopathic
  • manufactured_by:
  • TEVA PHARMACEUTICAL INDUSTRIES LTD

documents

localization

  • country:
  • دكساميسين
    إسرائيل
  • language:
  • العربية

therapeutic_information

  • therapeutic_group:
  • NEOMYCIN
  • therapeutic_indication:
  • Steroid-responsive allergic and inflammatory disorders of the anterior segments of the eye (conjunctival, corneal, or uveal tract inflammation) or mechanical, chemical or thermal trauma where bacterial infection or a risk of bacterial ocular infection exists.

status

  • source:
  • Ministry of Health - State of Israel
  • authorization_number:
  • 51032419900
  • authorization_date:
  • 01-10-2010
  • last_update:
  • 09-08-2016

doc_PIL: head_title_medicine_info

!

" # "

®

DexamethasoneSodiumPhosphate1mg

NeomycinSulfate5mg

Sodiumcitratedihydrate,creatinine,sodiumborate,sodiummetabisulfite,sodiumchloride,edetatedisodium,

benzalkoniumchloride,sodiumhydroxide,hydrochloricacid.

" # $

"

"

&

&

& '(

" # $ )

"

"

"

-------------------------------------------

" # $ -

----------------------------------------- --

"

" &

"

" ' ( ' '

& 25°C

"

0510324199

.'/0